Palvella therapeutics to present at the td cowen 45th annual healthcare conference

Wayne, pa., feb. 25, 2025 (globe newswire) -- (nasdaq: pvla) palvella therapeutics, inc. (palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no fda-approved therapies, today announced that its management team will present at the td cowen 45th annual healthcare conference on tuesday march 4, 2025, at 2:30 p.m. et. a live webcast of the presentation will be available on the events and presentations section of palvella's website at www.palvellatx.com.
COWN Ratings Summary
COWN Quant Ranking